Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-10

Clinical Trial Update: Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi [Phase 1]

View source ↗

Summary

Phase 1 clinical trial at a tertiary care hospital comparing silymarin versus N-acetylcysteine for preventing or reducing drug-induced liver injury in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)
  • Silymarin (silymarin)

Snippet

Sponsor: Liaquat National Hospital & Medical College | Conditions: Drug Induced Liver Injury, Tuberculosis (TB) | Phase 1 | Status: NOT_YET_RECRUITING